Item 2.02 Results of Operations and Financial Condition. On August 11, 2021, Royalty Pharma plc issued a press release announcing its financial results for the quarter ended June 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.




Item 9.01  Financial Statements and Exhibits
(d) Exhibits
Exhibit No.            Description
99.1                     Press release issued by Royalty Pharma plc, dated     August     11,
                       2021
104                    Cover Page Interactive Data File (embedded within the Inline XBRL
                       document)

© Edgar Online, source Glimpses